BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 23, 2003
View Archived Issues
Favorable effects on bone disease reported for lanthanum carbonate in hemodialysis
Read More
Lysostaphin cream as an alternative treatment for S. aureus infection
Read More
Etanercept does not increase the rate of malignancies in rheumatoid arthritis
Read More
PI3-kinase modulators with antiproliferative activity reported by Iconix
Read More
New antiinflammatory glucocorticoids in early development at GSK
Read More
Preparation and use of new GSK-3 inhibitors claimed by Servier
Read More
U. of Connecticut researchers identify novel cannabinoid agonists for pain and other uses
Read More
Pfizer claims new 5-HT4 receptor agonists with utility in gastrointestinal disorders
Read More
Scientists at Ortho-McNeil prepare dual inhibitors of cathepsin G and chymase
Read More
Novel antibacterial oxazolidinones prepared and tested by AstraZeneca researchers
Read More
New tissue-selective androgen receptor modulators discovered at Merck
Read More
Paladin licenses Visicol from InKine
Read More
MediGene completes enrollment in European part of phase III Polyphenon E trial
Read More
CytRx obtains license for DNA-based HIV vaccine
Read More
Data safety monitoring board clears phase III Thymitaq trial to continue
Read More
FDA approves Gleevec for Ph+ CML
Read More
Vertex reviews internal and partnered progress
Read More
Triapine in new phase II trial with gemcitabine for NSCLC
Read More
GW and Bayer enter marketing agreement for Sativex
Read More
GSK and Medivir sign licensing agreement for MIV-210
Read More
New immunosuppressive compound under development at Isotechnika
Read More
Extended-release alprazolam set for June launch
Read More
Phase II trial planned for GTI-2501 in metastatic prostate cancer
Read More
WX-UK1 cleared for phase I trials in the U.S.
Read More
CollaGenex signs agreement with EpiTan to develop topical formulation of Melanotan
Read More
Roche and Maxygen form interferon development alliance
Read More
First European country approves Fuzeon
Read More
Selectin inhibitor shows potential in the management of uveitis
Read More